Raja-Elie E Abdulnour, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Acute Lung Injury | 4 | 2019 | 380 | 1.130 |
Why?
|
Docosahexaenoic Acids | 6 | 2021 | 875 | 1.060 |
Why?
|
Hydrochloric Acid | 2 | 2019 | 76 | 0.830 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 3 | 2018 | 2282 | 0.720 |
Why?
|
Blood Platelet Disorders | 1 | 2018 | 58 | 0.620 |
Why?
|
Phospholipase D | 1 | 2018 | 70 | 0.620 |
Why?
|
Pneumonia, Bacterial | 2 | 2018 | 316 | 0.560 |
Why?
|
Leukocytes | 3 | 2019 | 2045 | 0.550 |
Why?
|
Lung | 8 | 2019 | 9857 | 0.510 |
Why?
|
Education, Medical | 2 | 2024 | 1722 | 0.460 |
Why?
|
Neutrophils | 5 | 2021 | 3721 | 0.430 |
Why?
|
Escherichia coli Infections | 1 | 2015 | 532 | 0.400 |
Why?
|
Pseudomonas Infections | 1 | 2015 | 613 | 0.390 |
Why?
|
Aspirin | 3 | 2016 | 3283 | 0.370 |
Why?
|
Phagocytosis | 3 | 2019 | 1539 | 0.310 |
Why?
|
Clinical Competence | 1 | 2022 | 4687 | 0.280 |
Why?
|
Xanthine Oxidase | 1 | 2006 | 64 | 0.280 |
Why?
|
Lipoxins | 2 | 2018 | 412 | 0.260 |
Why?
|
Disease Models, Animal | 6 | 2021 | 18034 | 0.260 |
Why?
|
Fatty Acids, Unsaturated | 2 | 2018 | 546 | 0.230 |
Why?
|
Blood Platelets | 1 | 2014 | 2509 | 0.230 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 625 | 0.230 |
Why?
|
Bronchoalveolar Lavage Fluid | 2 | 2015 | 768 | 0.220 |
Why?
|
Pneumonia | 3 | 2024 | 2133 | 0.220 |
Why?
|
Neuropeptides | 2 | 2019 | 942 | 0.220 |
Why?
|
Lung Diseases | 2 | 2018 | 1887 | 0.210 |
Why?
|
Radiation Pneumonitis | 1 | 2023 | 104 | 0.210 |
Why?
|
Hypersensitivity | 3 | 2021 | 1102 | 0.200 |
Why?
|
Stress, Mechanical | 1 | 2006 | 1686 | 0.190 |
Why?
|
Inflammation | 4 | 2024 | 10637 | 0.190 |
Why?
|
Neutrophil Activation | 1 | 2021 | 186 | 0.190 |
Why?
|
Lymphocytes | 2 | 2019 | 2617 | 0.180 |
Why?
|
Respiratory Mucosa | 2 | 2021 | 427 | 0.180 |
Why?
|
Receptors, Calcitonin Gene-Related Peptide | 1 | 2019 | 29 | 0.180 |
Why?
|
Pulmonary Edema | 3 | 2011 | 414 | 0.170 |
Why?
|
Leukotriene Antagonists | 1 | 2019 | 127 | 0.170 |
Why?
|
Receptors, IgE | 1 | 2021 | 389 | 0.170 |
Why?
|
MAP Kinase Signaling System | 1 | 2006 | 1525 | 0.160 |
Why?
|
Mice | 16 | 2024 | 81201 | 0.160 |
Why?
|
Health Facilities | 1 | 2024 | 572 | 0.160 |
Why?
|
Education, Distance | 1 | 2022 | 251 | 0.160 |
Why?
|
Leukotrienes | 1 | 2019 | 255 | 0.160 |
Why?
|
Mice, Inbred C57BL | 8 | 2019 | 21833 | 0.150 |
Why?
|
Calcitonin Gene-Related Peptide | 1 | 2019 | 306 | 0.150 |
Why?
|
Sepsis | 2 | 2021 | 2593 | 0.140 |
Why?
|
Nociceptors | 2 | 2021 | 432 | 0.140 |
Why?
|
Gene Expression | 3 | 2021 | 7798 | 0.140 |
Why?
|
Bronchi | 1 | 2019 | 840 | 0.130 |
Why?
|
Cytoprotection | 1 | 2015 | 210 | 0.130 |
Why?
|
Cysteine | 1 | 2019 | 873 | 0.130 |
Why?
|
Monocytes | 2 | 2021 | 2596 | 0.120 |
Why?
|
Platelet Activating Factor | 1 | 2014 | 149 | 0.120 |
Why?
|
Vitamin D Deficiency | 1 | 2024 | 1343 | 0.120 |
Why?
|
Arachidonate 12-Lipoxygenase | 1 | 2014 | 80 | 0.120 |
Why?
|
Animals | 17 | 2024 | 168768 | 0.120 |
Why?
|
Airway Remodeling | 1 | 2015 | 132 | 0.120 |
Why?
|
Macrophages | 2 | 2019 | 5660 | 0.120 |
Why?
|
Respiratory Hypersensitivity | 1 | 2015 | 274 | 0.110 |
Why?
|
Macrophages, Alveolar | 1 | 2015 | 407 | 0.110 |
Why?
|
Ventilators, Mechanical | 2 | 2006 | 292 | 0.110 |
Why?
|
Asthma | 2 | 2024 | 6010 | 0.110 |
Why?
|
Protein Isoforms | 1 | 2018 | 1730 | 0.110 |
Why?
|
Inflammation Mediators | 2 | 2021 | 1888 | 0.110 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2019 | 828 | 0.110 |
Why?
|
Pulmonary Alveoli | 1 | 2015 | 675 | 0.110 |
Why?
|
Immunity, Innate | 4 | 2019 | 2962 | 0.110 |
Why?
|
Double-Blind Method | 3 | 2023 | 12025 | 0.110 |
Why?
|
Mice, Knockout | 5 | 2021 | 14561 | 0.100 |
Why?
|
Thrombin | 1 | 2014 | 598 | 0.100 |
Why?
|
Cell Hypoxia | 1 | 2014 | 675 | 0.100 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2014 | 675 | 0.100 |
Why?
|
Bronchial Spasm | 1 | 2011 | 73 | 0.100 |
Why?
|
Platelet Transfusion | 1 | 2014 | 314 | 0.100 |
Why?
|
Molecular Structure | 1 | 2014 | 1899 | 0.090 |
Why?
|
NF-kappa B | 1 | 2018 | 2499 | 0.080 |
Why?
|
Mice, Inbred BALB C | 2 | 2016 | 6386 | 0.080 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2018 | 1344 | 0.080 |
Why?
|
Male | 17 | 2024 | 350115 | 0.080 |
Why?
|
Pseudomonas aeruginosa | 1 | 2015 | 1219 | 0.080 |
Why?
|
Cells, Cultured | 3 | 2019 | 19233 | 0.080 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2010 | 367 | 0.070 |
Why?
|
Lipid Metabolism | 1 | 2015 | 1889 | 0.070 |
Why?
|
Th2 Cells | 2 | 2024 | 1061 | 0.070 |
Why?
|
Protein Kinase Inhibitors | 1 | 2023 | 5534 | 0.070 |
Why?
|
Ovalbumin | 2 | 2021 | 719 | 0.070 |
Why?
|
T-Lymphocyte Subsets | 1 | 2014 | 1837 | 0.070 |
Why?
|
Pigment Epithelium of Eye | 1 | 2006 | 220 | 0.070 |
Why?
|
Metabolomics | 1 | 2014 | 1485 | 0.070 |
Why?
|
Thalassemia | 1 | 2006 | 273 | 0.070 |
Why?
|
Capillary Permeability | 2 | 2006 | 798 | 0.070 |
Why?
|
Intention to Treat Analysis | 1 | 2016 | 426 | 0.060 |
Why?
|
Recombinant Proteins | 1 | 2014 | 6621 | 0.060 |
Why?
|
Immunotherapy | 1 | 2020 | 4446 | 0.060 |
Why?
|
Lipids | 1 | 2015 | 3307 | 0.060 |
Why?
|
Lymphocyte Activation | 1 | 2014 | 5524 | 0.060 |
Why?
|
Electronic Health Records | 1 | 2020 | 4468 | 0.060 |
Why?
|
Humans | 18 | 2024 | 744366 | 0.060 |
Why?
|
Escherichia coli | 1 | 2015 | 4217 | 0.060 |
Why?
|
Intubation, Intratracheal | 1 | 2011 | 1364 | 0.060 |
Why?
|
Pulmonary Circulation | 1 | 2006 | 739 | 0.060 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2006 | 697 | 0.050 |
Why?
|
Nitric Oxide Synthase | 1 | 2005 | 915 | 0.050 |
Why?
|
Severity of Illness Index | 1 | 2019 | 15535 | 0.050 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2014 | 2988 | 0.050 |
Why?
|
Immunologic Tests | 1 | 2021 | 103 | 0.050 |
Why?
|
Retinal Diseases | 1 | 2006 | 684 | 0.050 |
Why?
|
Female | 10 | 2024 | 380193 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2018 | 21748 | 0.040 |
Why?
|
Enzyme Activation | 1 | 2006 | 3702 | 0.040 |
Why?
|
Substance P | 1 | 2021 | 335 | 0.040 |
Why?
|
Vision Disorders | 1 | 2006 | 1058 | 0.040 |
Why?
|
Leukocyte Elastase | 1 | 2019 | 113 | 0.040 |
Why?
|
GPI-Linked Proteins | 1 | 2019 | 435 | 0.040 |
Why?
|
Principal Component Analysis | 1 | 2021 | 940 | 0.040 |
Why?
|
Transcription, Genetic | 2 | 2017 | 7721 | 0.040 |
Why?
|
Vagus Nerve | 1 | 2021 | 439 | 0.040 |
Why?
|
Prednisone | 1 | 2023 | 1574 | 0.040 |
Why?
|
Neuroimmunomodulation | 1 | 2019 | 157 | 0.040 |
Why?
|
Visual Acuity | 1 | 2006 | 2530 | 0.040 |
Why?
|
Receptors, Neurotransmitter | 1 | 2017 | 178 | 0.040 |
Why?
|
Receptors, Interleukin-1 | 1 | 2018 | 262 | 0.040 |
Why?
|
Interleukin-2 | 1 | 2024 | 1904 | 0.040 |
Why?
|
Feedback, Physiological | 1 | 2019 | 479 | 0.040 |
Why?
|
Middle Aged | 5 | 2021 | 213390 | 0.030 |
Why?
|
Receptors, IgG | 1 | 2019 | 582 | 0.030 |
Why?
|
Adult | 6 | 2020 | 214052 | 0.030 |
Why?
|
Aged | 4 | 2020 | 163288 | 0.030 |
Why?
|
Leukocyte Count | 1 | 2019 | 1588 | 0.030 |
Why?
|
Vitamins | 1 | 2024 | 1623 | 0.030 |
Why?
|
Freund's Adjuvant | 1 | 2015 | 139 | 0.030 |
Why?
|
Immunity, Cellular | 1 | 2021 | 1607 | 0.030 |
Why?
|
Vasoactive Intestinal Peptide | 1 | 2015 | 179 | 0.030 |
Why?
|
Interleukin-5 | 1 | 2015 | 273 | 0.030 |
Why?
|
Minor Histocompatibility Antigens | 1 | 2015 | 298 | 0.030 |
Why?
|
Capsaicin | 1 | 2015 | 232 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1782 | 0.030 |
Why?
|
Endothelium, Vascular | 1 | 2006 | 4459 | 0.030 |
Why?
|
Diagnosis, Differential | 2 | 2024 | 12961 | 0.030 |
Why?
|
Allergens | 1 | 2021 | 1320 | 0.030 |
Why?
|
Triage | 1 | 2020 | 977 | 0.030 |
Why?
|
Adaptive Immunity | 1 | 2018 | 714 | 0.030 |
Why?
|
Length of Stay | 1 | 2016 | 6311 | 0.030 |
Why?
|
Signal Transduction | 3 | 2021 | 23404 | 0.030 |
Why?
|
Adoptive Transfer | 1 | 2014 | 844 | 0.030 |
Why?
|
Lidocaine | 1 | 2015 | 544 | 0.030 |
Why?
|
Interleukin-17 | 1 | 2017 | 901 | 0.020 |
Why?
|
Immunomodulation | 1 | 2014 | 541 | 0.020 |
Why?
|
Laryngismus | 1 | 2010 | 29 | 0.020 |
Why?
|
Ligands | 1 | 2017 | 3282 | 0.020 |
Why?
|
Vitamin D | 1 | 2024 | 3224 | 0.020 |
Why?
|
Cytokines | 2 | 2015 | 7323 | 0.020 |
Why?
|
Time Factors | 2 | 2016 | 40075 | 0.020 |
Why?
|
Laryngeal Masks | 1 | 2010 | 99 | 0.020 |
Why?
|
Animals, Newborn | 1 | 2015 | 2726 | 0.020 |
Why?
|
Green Fluorescent Proteins | 1 | 2015 | 2088 | 0.020 |
Why?
|
Blotting, Western | 1 | 2016 | 5181 | 0.020 |
Why?
|
Anesthetics, Local | 1 | 2015 | 985 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2010 | 15297 | 0.020 |
Why?
|
Incidence | 1 | 2016 | 20952 | 0.020 |
Why?
|
Calcium | 1 | 2021 | 5755 | 0.020 |
Why?
|
Positive-Pressure Respiration | 1 | 2011 | 633 | 0.020 |
Why?
|
Respiratory Function Tests | 1 | 2011 | 1617 | 0.020 |
Why?
|
Emergency Service, Hospital | 1 | 2016 | 7658 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2015 | 4208 | 0.020 |
Why?
|
Disease Progression | 1 | 2023 | 13286 | 0.020 |
Why?
|
Respiratory Sounds | 1 | 2010 | 696 | 0.020 |
Why?
|
Delivery of Health Care | 1 | 2024 | 5321 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2020 | 57776 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2019 | 10483 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 2015 | 4561 | 0.010 |
Why?
|
Cell Line | 1 | 2018 | 16000 | 0.010 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2005 | 534 | 0.010 |
Why?
|
Cross-Sectional Studies | 2 | 2019 | 25039 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2016 | 11366 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2014 | 9735 | 0.010 |
Why?
|
Phenotype | 1 | 2019 | 16367 | 0.010 |
Why?
|
Neurons | 1 | 2021 | 9340 | 0.010 |
Why?
|
Acute Disease | 1 | 2010 | 7147 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2017 | 12073 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2021 | 17446 | 0.010 |
Why?
|
Echocardiography | 1 | 2011 | 5099 | 0.010 |
Why?
|
United States | 1 | 2016 | 69872 | 0.010 |
Why?
|
Electrocardiography | 1 | 2011 | 6442 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 4751 | 0.010 |
Why?
|
Up-Regulation | 1 | 2005 | 4222 | 0.010 |
Why?
|
Young Adult | 1 | 2019 | 56429 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2010 | 39052 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2011 | 20130 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2010 | 63107 | 0.000 |
Why?
|
Adolescent | 1 | 2006 | 85779 | 0.000 |
Why?
|